What is Myriad Genetics's financing cash flow?

Myriad Genetics (MYGN) reported financing cash flow of -$3M in Q1 2026.

How has Myriad Genetics's financing cash flow changed year-over-year?

Myriad Genetics's financing cash flow decreased by 122.1% year-over-year, from $13.6M to -$3M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Myriad Genetics MYGN Financing Cash Flow

Financing Cash Flow at other companies

Labcorp HoldingsLH

$580.5M+169%

Quest DiagnosticsDGX

-$152M+72.9%

NeoGenomicsNEO

-$338K-136%

VeracyteVCYT

-$6.63M-2.2%

Guardant HealthGH

-$21.58M+67.7%

Natera, Inc.NTRA

$3.76M+591%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's financing cash flow?: Myriad Genetics (MYGN) reported financing cash flow of -$3M in Q1 2026.
How has Myriad Genetics's financing cash flow changed year-over-year?: Myriad Genetics's financing cash flow decreased by 122.1% year-over-year, from $13.6M to -$3M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.